Skip to main content
Equibles

DAFNA Capital Management LLC

Position in IBIO — iBio, Inc.

CIK 1389933 LOS ANGELES, CA
Back to IBIO Full portfolio

Position in IBIO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$297,592
-$70,320 QoQ
Shares Held
170,053
-12.2% QoQ
Ownership
0.264%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#30
of 55 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IBIO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DAFNA Capital Management LLC holds $345,637,467 across 65 Biotechnology names. IBIO ranks #59 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 562,630 $105,369,346
2 NKTR
Nektar Therapeutics
 318,380 $22,226,107
3 DNLI
Denali Therapeutics Inc.
 739,014 $19,007,440
4 IDYA
IDEAYA Biosciences, Inc.
 497,240 $18,532,134
5 XENE
Xenon Pharmaceuticals Inc.
 250,772 $15,136,597
6 CYTK
Cytokinetics Inc
 171,998 $14,652,509
7 RCUS
Arcus Biosciences, Inc.
 441,829 $13,621,588
8 ASND
Ascendis Pharma A/S
 48,469 $12,927,651

All Filings in IBIO

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $297,592 170,053
2026-03-31 $367,912 193,638